FGFR1 and cholangiocarcinoma: Rizvi et al. recently reported that in cholangiocarcinoma, Yes-associated protein (YAP), a transcriptional coactivator and the key regulator of the Hippo pathway, interacts with TBX5, a transcription factor that binds to the promoter region of FGFR1 [15].